CD86 and neoplasm: We found that the intra-T/peri-T ratio of CD86+ cells was significantly lower in CD68+ (pan-macrophage marker) cells than CD20+ tumor B cells (0.4 ± 0.1 vs 1.4 ± 0.4, p = 3e-13) (Figure 5A).